ARHGEF17 and lung cancer: The presence of Gβγ in the active fraction of ARHGEF17 (Fig. 4, E and F) supported a potential mechanistic link between these signaling proteins relevant to drive actin cytoskeleton reorganization and cell migration in lung cancer cells responding to LPA (Fig. 5A).